You are viewing the site in preview mode
Skip to main content
|
Demographic
|
Article %
|
|---|
|
Funding source
|
|
private
|
50.0% (23/46)
|
|
public
|
43.5% (20/46)
|
|
not mentioned/other
|
21.7% (10/46)
|
|
industry
|
10.9% (5/46)
|
|
hospital
|
4.3% (2/46)
|
|
Study design
|
|
parallel arm
|
73.7% (35/46)
|
|
crossover
|
13.0% (6/46)
|
|
factorial
|
8.7% (4/46)
|
|
Intervention
|
|
pharmacological
|
76.1% (35/46)
|
|
non-pharmacological
|
23.9% (11/46)
|
|
Blinding
|
|
no blinding/not specified
|
69.6% (32/46)
|
|
double-binded
|
21.7% (10/46)
|
|
single-blinded
|
8.7% (4/46)
|
|
Stated adherence to TIDieR
|
|
no
|
100% (46/46)
|
|
yes
|
0% (0/46)
|
